IL17A and systemic lupus erythematosus: Considering the findings of recent studies indicating the direct suppression of effector T cell proliferation and function by IL-35 in vitro11,21, we speculated that IL-35+ Bregs and their functional cytokine IL-35 might suppress the Th17/IL-17 axis, thus playing a protective role in the pathogenesis of SLE.